- Home
- TRT vs ADAP Comparison
TRT vs ADAP Comparison
Compare TRT & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- ADAP
- Stock Information
- Founded
- TRT 1958
- ADAP 2008
- Country
- TRT United States
- ADAP United Kingdom
- Employees
- TRT N/A
- ADAP N/A
- Industry
- TRT Industrial Machinery/Components
- ADAP Biotechnology: Pharmaceutical Preparations
- Sector
- TRT Technology
- ADAP Health Care
- Exchange
- TRT Nasdaq
- ADAP Nasdaq
- Market Cap
- TRT 24.4M
- ADAP 21.3M
- IPO Year
- TRT N/A
- ADAP 2015
- Fundamental
- Price
- TRT $5.57
- ADAP $0.06
- Analyst Decision
- TRT
- ADAP Hold
- Analyst Count
- TRT 0
- ADAP 6
- Target Price
- TRT N/A
- ADAP $1.02
- AVG Volume (30 Days)
- TRT 2.3K
- ADAP 57.1M
- Earning Date
- TRT 09-22-2025
- ADAP 08-13-2025
- Dividend Yield
- TRT N/A
- ADAP N/A
- EPS Growth
- TRT N/A
- ADAP N/A
- EPS
- TRT 0.00
- ADAP N/A
- Revenue
- TRT $35,548,000.00
- ADAP $65,084,999.00
- Revenue This Year
- TRT N/A
- ADAP N/A
- Revenue Next Year
- TRT N/A
- ADAP $38.72
- P/E Ratio
- TRT $1,287.03
- ADAP N/A
- Revenue Growth
- TRT N/A
- ADAP N/A
- 52 Week Low
- TRT $4.62
- ADAP $0.06
- 52 Week High
- TRT $7.88
- ADAP $1.33
- Technical
- Relative Strength Index (RSI)
- TRT 52.22
- ADAP 27.38
- Support Level
- TRT $5.54
- ADAP $0.08
- Resistance Level
- TRT $5.76
- ADAP $0.09
- Average True Range (ATR)
- TRT 0.10
- ADAP 0.01
- MACD
- TRT -0.00
- ADAP -0.00
- Stochastic Oscillator
- TRT 59.57
- ADAP 0.33
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.